XT
DRMA icon

XTX Topco’s Dermata Therapeutics DRMA Stock Holding History

XTX Topco’s Portfolio DRMA Stock Details DRMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,449
Closed -$20.2K – 2720
2025
Q2 		$20.2K Buy
+3,449
New +$26.4K ﹤0.01% 2162

Other funds holding DRMA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's DRMA Position: Q3 2025 in Review

XTX Topco sold out of Dermata Therapeutics (DRMA) in Q3 2025, closing a stake of 3,449 shares — an estimated $20.2K sold.

XTX Topco first reported a position in DRMA in Q2 2025 and held it in 1 quarter. The position peaked at $20.2K in Q2 2025. 5 funds tracked by Wall St. Rank hold DRMA as of Q3 2025.

  • XTX Topco reported no remaining Dermata Therapeutics position as of Q3 2025 after selling out during the quarter.
  • XTX Topco sold 3,449 Dermata Therapeutics shares in Q3 2025, an estimated $20.2K.
  • XTX Topco first reported a position in Dermata Therapeutics in Q2 2025 and held it in 1 quarter.
  • XTX Topco's Dermata Therapeutics position peaked at $20.2K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Dermata Therapeutics as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.